Impact of Hyperhomocysteinemia and Different Dietary Interventions on Cognitive Performance in a Knock-in Mouse Model for Alzheimer’s Disease

Background: Hyperhomocysteinemia is considered a possible contributor to the complex pathology of Alzheimer’s disease (AD). For years, researchers in this field have discussed the apparent detrimental effects of the endogenous amino acid homocysteine in the brain. In this study, the roles of hyperhomocysteinemia driven by vitamin B deficiency, as well as potentially beneficial dietary interventions, were investigated in the novel AppNL-G-F knock-in mouse model for AD, simulating an early stage of the disease. Methods: Urine and serum samples were analyzed using a validated LC-MS/MS method and the impact of different experimental diets on cognitive performance was studied in a comprehensive behavioral test battery. Finally, we analyzed brain samples immunohistochemically in order to assess amyloid-β (Aβ) plaque deposition. Results: Behavioral testing data indicated subtle cognitive deficits in AppNL-G-F compared to C57BL/6J wild type mice. Elevation of homocysteine and homocysteic acid, as well as counteracting dietary interventions, mostly did not result in significant effects on learning and memory performance, nor in a modified Aβ plaque deposition in 35-week-old AppNL-G-F mice. Conclusion: Despite prominent Aβ plaque deposition, the AppNL-G-F model merely displays a very mild AD-like phenotype at the investigated age. Older AppNL-G-F mice should be tested in order to further investigate potential effects of hyperhomocysteinemia and dietary interventions.

[1]  J. Reichert,et al.  Antibodies to watch in 2020 , 2019, mAbs.

[2]  V. Calsolaro,et al.  The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease , 2019, Front. Pharmacol..

[3]  P. Skolnick,et al.  Be positive about negatives–recommendations for the publication of negative (or null) results , 2019, European Neuropsychopharmacology.

[4]  D. Balschun,et al.  Neural oscillations during cognitive processes in an App knock-in mouse model of Alzheimer’s disease pathology , 2019, Scientific Reports.

[5]  N. Ferreirós,et al.  A validated LC-MS/MS method for the determination of homocysteic acid in biological samples. , 2019, Journal of pharmaceutical and biomedical analysis.

[6]  T. Saido,et al.  Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer’s disease , 2019, BMC Neuroscience.

[7]  R. J. McDonald,et al.  Age-dependent behavioral and biochemical characterization of single APP knock-in mouse (APPNL-G-F/NL-G-F) model of Alzheimer's disease , 2019, Neurobiology of Aging.

[8]  Piyoosh Sharma,et al.  Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies , 2019, Progress in Neurobiology.

[9]  G. Logroscino,et al.  A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease , 2019, Nature Reviews Neurology.

[10]  W. M. van der Flier,et al.  Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease , 2019, Alzheimer's & dementia.

[11]  H. Fillit,et al.  Translating the biology of aging into novel therapeutics for Alzheimer disease , 2018, Neurology.

[12]  J. Kotlinska,et al.  Assessment of spatial learning and memory in the Barnes maze task in rodents—methodological consideration , 2018, Naunyn-Schmiedeberg's Archives of Pharmacology.

[13]  T. Saido,et al.  Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis , 2018, BMC Neuroscience.

[14]  A. Beery,et al.  Inclusion of females does not increase variability in rodent research studies , 2018, Current Opinion in Behavioral Sciences.

[15]  G. Zhu,et al.  Betaine in Inflammation: Mechanistic Aspects and Applications , 2018, Front. Immunol..

[16]  M. Fenech,et al.  Homocysteine and Dementia: An International Consensus Statement , 2018, Journal of Alzheimer's disease : JAD.

[17]  T. Saido,et al.  Reduction in open field activity in the absence of memory deficits in the App NL−G−F knock-in mouse model of Alzheimer’s disease , 2018, Behavioural Brain Research.

[18]  Hui Zheng,et al.  Practical considerations for choosing a mouse model of Alzheimer’s disease , 2017, Molecular Neurodegeneration.

[19]  R. D'Hooge,et al.  Subtle behavioral changes and increased prefrontal-hippocampal network synchronicity in APPNL−G−F mice before prominent plaque deposition , 2017, Behavioural Brain Research.

[20]  H. Lipp,et al.  Automated dissection of permanent effects of hippocampal or prefrontal lesions on performance at spatial, working memory and circadian timing tasks of C57BL/6 mice in IntelliCage , 2017, Behavioural Brain Research.

[21]  B. Winblad,et al.  APP mouse models for Alzheimer's disease preclinical studies , 2017, The EMBO journal.

[22]  D. Michaelson,et al.  Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer’s disease: a rationale for multi-nutrient dementia prevention , 2017, Journal of Lipid Research.

[23]  J. McCabe,et al.  Behavior of Male and Female C57BL/6J Mice Is More Consistent with Repeated Trials in the Elevated Zero Maze than in the Elevated Plus Maze , 2017, Front. Behav. Neurosci..

[24]  S. Itohara,et al.  Cognitive deficits in single App knock-in mouse models , 2016, Neurobiology of Learning and Memory.

[25]  A. Smith,et al.  Homocysteine, B Vitamins, and Cognitive Impairment. , 2016, Annual review of nutrition.

[26]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[27]  Valerio Zerbi,et al.  A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 Mice , 2016, Neural plasticity.

[28]  D. Kennedy B Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review , 2016, Nutrients.

[29]  A. Smith,et al.  Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment , 2016, Journal of Alzheimer's disease : JAD.

[30]  A. Rutjes,et al.  Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. , 2015, The Cochrane database of systematic reviews.

[31]  D. Clair,et al.  Bridging the translational divide: identical cognitive touchscreen testing in mice and humans carrying mutations in a disease-relevant homologous gene , 2015, Scientific Reports.

[32]  G. Dubey,et al.  Age dependent levels of plasma homocysteine and cognitive performance , 2015, Behavioural Brain Research.

[33]  R. Collins,et al.  Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals , 2014, The American journal of clinical nutrition.

[34]  S. Itohara,et al.  Single App knock-in mouse models of Alzheimer's disease , 2014, Nature Neuroscience.

[35]  P. Vemuri,et al.  Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences , 2014, Clinical epidemiology.

[36]  Stephen A. Rappaport,et al.  The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease , 2013, Alzheimer's Research & Therapy.

[37]  L. Joosten,et al.  Effects of Specific Multi-Nutrient Enriched Diets on Cerebral Metabolism, Cognition and Neuropathology in AβPPswe-PS1dE9 Mice , 2013, PloS one.

[38]  Thomas E. Nichols,et al.  Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment , 2013, Proceedings of the National Academy of Sciences.

[39]  Charles D. Smith,et al.  Induction of Hyperhomocysteinemia Models Vascular Dementia by Induction of Cerebral Microhemorrhages and Neuroinflammation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  Nick C Fox,et al.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.

[41]  J. Roder,et al.  Assessment of Social Interaction Behaviors , 2011, Journal of visualized experiments : JoVE.

[42]  S. Chakrabarti,et al.  Aging and antioxidants modulate rat brain levels of homocysteine and dehydroepiandrosterone sulphate (DHEA-S): Implications in the pathogenesis of Alzheimer's disease , 2010, Neuroscience Letters.

[43]  K Safi,et al.  Consistent behavioral phenotype differences between inbred mouse strains in the IntelliCage , 2010, Genes, brain, and behavior.

[44]  Abderrahim Oulhaj,et al.  Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial , 2010, PloS one.

[45]  K. Zahs,et al.  ‘Too much good news’ – are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease? , 2010, Trends in Neurosciences.

[46]  D. Wald,et al.  Effect of folic acid, with or without other B vitamins, on cognitive decline: meta-analysis of randomized trials. , 2010, The American journal of medicine.

[47]  F. LaFerla,et al.  Treatment of Alzheimer's Disease with Anti-Homocysteic Acid Antibody in 3xTg-AD Male Mice , 2010, PloS one.

[48]  V. Bolivar Intrasession and intersession habituation in mice: From inbred strain variability to linkage analysis , 2009, Neurobiology of Learning and Memory.

[49]  L. Saksida,et al.  A novel touchscreen-automated paired-associate learning (PAL) task sensitive to pharmacological manipulation of the hippocampus: a translational rodent model of cognitive impairments in neurodegenerative disease , 2009, Psychopharmacology.

[50]  Q. Tian,et al.  Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. , 2009, The American journal of pathology.

[51]  Jeffrey A. James,et al.  Frequent amyloid deposition without significant cognitive impairment among the elderly. , 2008, Archives of neurology.

[52]  B. Shukitt-Hale,et al.  B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice , 2008, Proceedings of the National Academy of Sciences.

[53]  F. D’Anselmi,et al.  B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-β deposition in mice , 2008, Molecular and Cellular Neuroscience.

[54]  R. Leighty,et al.  A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer’s transgenic mice , 2007, Neuroscience.

[55]  A. Drzezga,et al.  Gender differences in brain reserve , 2007, Journal of Neurology.

[56]  M. P. McDonald,et al.  Impaired spatial memory in APP-overexpressing mice on a homocysteinemia-inducing diet , 2007, Neurobiology of Aging.

[57]  G. Weaving,et al.  Behavioural and Psychological Symptoms of Alzheimer Type Dementia Are Not Correlated with Plasma Homocysteine Concentration , 2006, Dementia and Geriatric Cognitive Disorders.

[58]  A. Tomarken,et al.  Spatial and nonspatial escape strategies in the Barnes maze. , 2006, Learning & memory.

[59]  A. Boldyrev,et al.  Effect of homocysteine and homocysteic acid on glutamate receptors on rat lymphocytes , 2006, Bulletin of Experimental Biology and Medicine.

[60]  J. Mann,et al.  A controlled trial of homocysteine lowering and cognitive performance. , 2006, The New England journal of medicine.

[61]  R. Obeid,et al.  Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia , 2006, FEBS letters.

[62]  Knut Engedal,et al.  Plasma total homocysteine and memory in the elderly: The Hordaland Homocysteine study , 2005, Annals of neurology.

[63]  Y. Terayama,et al.  Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease. , 2005, Life sciences.

[64]  J. Nadeau,et al.  Homocysteine levels in A/J and C57BL/6J mice: genetic, diet, gender, and parental effects. , 2005, Physiological genomics.

[65]  J. Piven,et al.  Sociability and preference for social novelty in five inbred strains: an approach to assess autistic‐like behavior in mice , 2004, Genes, brain, and behavior.

[66]  G. Schwall,et al.  Molecular analysis of homocysteic acid-induced neuronal stress. , 2004, Journal of proteome research.

[67]  M. Siebler,et al.  Implications for hyperhomocysteinemia: not homocysteine but its oxidized forms strongly inhibit neuronal network activity , 2004, Journal of the Neurological Sciences.

[68]  M. S. Morris Homocysteine and Alzheimer's disease , 2003, The Lancet Neurology.

[69]  M. Mattson,et al.  Folic Acid Deficiency and Homocysteine Impair DNA Repair in Hippocampal Neurons and Sensitize Them to Amyloid Toxicity in Experimental Models of Alzheimer's Disease , 2002, The Journal of Neuroscience.

[70]  Sudha Seshadri,et al.  Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .

[71]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[72]  R. Diaz-Arrastia,et al.  Homocysteine and neurologic disease. , 2000, Archives of neurology.

[73]  W. Kukull,et al.  Anxiety of Alzheimer's disease: prevalence, and comorbidity. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[74]  R Clarke,et al.  Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. , 1998, Archives of neurology.

[75]  H. Brodaty,et al.  ALZHEIMER'S DISEASE INTERNATIONAL , 1997, International journal of geriatric psychiatry.

[76]  Santhosh K. P. Kumar,et al.  Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[77]  D. Choi,et al.  l-Homocysteate is a potent neurotoxin on cultured cortical neurons , 1987, Brain Research.

[78]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[79]  J. Homberg,et al.  Impact of dietary n-3 polyunsaturated fatty acids on cognition, motor skills and hippocampal neurogenesis in developing C57BL/6J mice. , 2015, The Journal of nutritional biochemistry.

[80]  S. Itohara,et al.  Single APP knockin mouse models of Alzheimer’s disease , 2014 .

[81]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[82]  Jia-min Zhuo,et al.  Severe In vivo hyper-homocysteinemia is not associatedwith elevation of amyloid-beta peptides in the Tg2576 mice. , 2010, Journal of Alzheimer's disease : JAD.

[83]  A. Smith,et al.  Facts and recommendations about total homocysteine determinations: an expert opinion. , 2004, Clinical chemistry.

[84]  S. Vollset,et al.  The Hordaland Homocysteine Studies , 2001, Lipids.